ABUS — Arbutus Biopharma Corp

Price

$3.66

Change

-0.02 (-0.41%)

Open

$3.65

High

$3.75

Low

$3.63

Prev close

$3.67

Volume

1.7M

On NASDAQ, Arbutus Biopharma Corp trades as ABUS.

Its activity is classified under HEALTHCARE, in the BIOTECHNOLOGY industry.

Searching for the Arbutus Biopharma Corp share price, or whether to buy ABUS? This page brings together a live chart, momentum and risk scores, fresh news and community sentiment.

VAQO runs a statistical model over ABUS that reads seven technical indicators and translates them into an opportunity score and a risk score — including which factors drove them.

What ABUS is

Arbutus Biopharma Corporation, a biopharmaceutical company, is dedicated to the discovery, development, and commercialization of a cure for patients with chronic hepatitis B virus (HBV) infection in the United States. The company is headquartered in Warminster, Pennsylvania.…

Arbutus Biopharma Corp is classified under HEALTHCARE, in the BIOTECHNOLOGY industry.

It trades on NASDAQ as a common stock.

ABUS size and valuation

At roughly $686.7M, ABUS is a small-cap.

It earns 0.79 per share and trades at 5.7 times that, a multiple that implies the market expects little growth.

Beta is 0.76: historically it has moved less than the market.

ABUS over the past year

Over the past year ABUS has traded between $3.50 and $5.45, and the current price sits at 8% of that range.

Trading near the low end of a 52-week range is a different situation from a bad day: it means the year, not the session, has gone against it.

The 50-day average is $4.84 against a 200-day average of $4.54 — the shorter average sits above the longer one, the configuration usually read as an uptrend.

The published analyst target is $5.36, 46.6% above it. A target is an aggregate of opinions, not a measurement.

How Arbutus Biopharma Corp (ABUS) is trading

Arbutus Biopharma Corp (ABUS) trades at $3.66, close to unchanged in the latest session (-0.41%).

The session ranged from $3.63 to $3.75 — 3.4% of the share price — and the current price sits at 24% of that range.

The session covered 3.4% of ground and ended almost where it started — a lot of movement without direction.

Volume ran near 1.7M shares, about $6.3M of stock changing hands.

Traded alongside ABUS

Names traded alongside ABUS in the same sector: A (Agilent Technologies Inc), AAPG (Ascentage Pharma Group International), AARD (Aardvark Therapeutics Inc), ABCL (AbCellera Biologics Inc), ABEO (Abeona Therapeutics Inc).

What VAQO's model says about ABUS

Two statistical models run over ABUS inside the browser, reporting momentum, risk and opportunity separately. Full accuracy for both, including when it falls, is published on the model page.

Key facts

Symbol: ABUS
Name: Arbutus Biopharma Corp
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Exchange: NASDAQ
Instrument: Stock

ABUS — frequently asked questions

What is the market cap of ABUS?

Arbutus Biopharma Corp has a market capitalisation of roughly $686.7M.

What is the 52-week range for ABUS?

ABUS has traded between $3.50 and $5.45 over the past year, with the current price at 8% of that range.

What is the P/E ratio of ABUS?

ABUS trades at 5.7 times earnings, on earnings per share of 0.79.

How much does ABUS stock cost today?

Arbutus Biopharma Corp (ABUS) trades at $3.66, a change of -0.41% in the latest session.

Is ABUS up or down today?

ABUS is down 0.41% in the latest session, at $3.66.

What is the daily trading range for ABUS?

ABUS traded between $3.63 and $3.75 in the latest session, and currently trades at $3.66.

What is the trading volume for ABUS?

ABUS traded roughly 1.7M shares in the latest session.

Which exchange is ABUS listed on?

ABUS is listed on NASDAQ, in the HEALTHCARE sector.

Should I buy ABUS stock?

VAQO gives no buy or sell recommendations and is not an investment adviser. The ABUS figures on this page — price, range, volume and the model's scores — are there to inform your decision, not to stand in for it.

Others in HEALTHCARE

← All stocks on VAQO

Last updated: 2026-11-08